Dehydropachymic acidCAS# 77012-31-8 |
- 3-Epidehydropachymic acid
Catalog No.:BCN3644
CAS No.:168293-15-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 77012-31-8 | SDF | Download SDF |
| PubChem ID | 15226717 | Appearance | Powder |
| Formula | C33H50O5 | M.Wt | 526.8 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in chloroform | ||
| Chemical Name | (2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3-acetyloxy-16-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid | ||
| SMILES | CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)O)C(=O)O | ||
| Standard InChIKey | RWIALJIVPUCERT-DRCQUEPLSA-N | ||
| Standard InChI | InChI=1S/C33H50O5/c1-19(2)20(3)10-11-22(29(36)37)28-25(35)18-33(9)24-12-13-26-30(5,6)27(38-21(4)34)15-16-31(26,7)23(24)14-17-32(28,33)8/h12,14,19,22,25-28,35H,3,10-11,13,15-18H2,1-2,4-9H3,(H,36,37)/t22-,25-,26+,27+,28+,31-,32-,33+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Dehydropachymic acid shows antiinflammatory activity. |
| Targets | Immunology & Inflammation related |
Dehydropachymic acid Dilution Calculator
Dehydropachymic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.8983 mL | 9.4913 mL | 18.9825 mL | 37.9651 mL | 47.4563 mL |
| 5 mM | 0.3797 mL | 1.8983 mL | 3.7965 mL | 7.593 mL | 9.4913 mL |
| 10 mM | 0.1898 mL | 0.9491 mL | 1.8983 mL | 3.7965 mL | 4.7456 mL |
| 50 mM | 0.038 mL | 0.1898 mL | 0.3797 mL | 0.7593 mL | 0.9491 mL |
| 100 mM | 0.019 mL | 0.0949 mL | 0.1898 mL | 0.3797 mL | 0.4746 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (+,-)-Octopamine HCl
Catalog No.:BCC4814
CAS No.:770-05-8
- D-(-)-Quinic acid
Catalog No.:BCN1029
CAS No.:77-95-2
- Triethyl citrate
Catalog No.:BCC9186
CAS No.:77-93-0
- Citric acid
Catalog No.:BCN5374
CAS No.:77-92-9
- Trometamol
Catalog No.:BCC4743
CAS No.:77-86-1
- Tigogenin
Catalog No.:BCN5327
CAS No.:77-60-1
- Tomatidine
Catalog No.:BCN2773
CAS No.:77-59-8
- Cedrol
Catalog No.:BCN8340
CAS No.:77-53-2
- Ursolic acid
Catalog No.:BCN4327
CAS No.:77-52-1
- Chlorthalidone
Catalog No.:BCC4649
CAS No.:77-36-1
- Gibberellins
Catalog No.:BCN2189
CAS No.:77-06-5
- Garcinone C
Catalog No.:BCN4322
CAS No.:76996-27-5
- Hypocrellin A
Catalog No.:BCN3396
CAS No.:77029-83-5
- Knightinol
Catalog No.:BCN1913
CAS No.:77053-06-6
- Acetylknightinol
Catalog No.:BCN1914
CAS No.:77053-07-7
- Gadobutrol
Catalog No.:BCC4164
CAS No.:770691-21-9
- 6-O-trans-Feruloylcatalpol
Catalog No.:BCN4323
CAS No.:125205-48-3
- 2H-1-Benzopyran-5-ol
Catalog No.:BCN3581
CAS No.:770729-34-5
- MK-801 (Dizocilpine)
Catalog No.:BCC4591
CAS No.:77086-21-6
- (+)-MK 801 Maleate
Catalog No.:BCC4014
CAS No.:77086-22-7
- 1H-Indole-3-carboxylic acid
Catalog No.:BCN4324
CAS No.:771-50-6
- Fmoc-Sar-OH
Catalog No.:BCC3338
CAS No.:77128-70-2
- Fmoc-Phe(4-OMe)-OH,Fmoc-Tyr(Me)-OH
Catalog No.:BCC2634
CAS No.:77128-72-4
- Fmoc-N-Me-Phe-OH
Catalog No.:BCC2614
CAS No.:77128-73-5
Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7.[Pubmed:23588713]
Int J Oncol. 2013 Jun;42(6):1869-74.
Poria cocos is a medicinal mushroom that is widely used in traditional Asian medicine. Here, we show that a characterized mixture of triterpenes extracted from P. cocos (PTE) and three purified triterpenes: pachymic acid (PA), Dehydropachymic acid (DPA) and polyporenic acid C (PPAC) suppress the proliferation of the human pancreatic cancer cell lines Panc-1, MiaPaca-2, AsPc-1 and BxPc-3. Moreover, the most effective compound, PA, only slightly affects the proliferation of HPDE-6 normal pancreatic duct epithelial cells. The anti-proliferative effects of PTE on BxPc-3 cells are mediated by the cell cycle arrest at G0/G1 phase. DNA microarray analysis demonstrated that PTE significantly downregulates the expression of KRAS and matrix metalloproteinase-7 (MMP-7) in BxPc-3 cells. In addition, PTE and PA suppress the invasive behavior of BxPc-3 cells. The inhibition of invasiveness by PTE and PA was associated with the reduction of MMP-7 at the protein level and the role of MMP-7 further confirmed by the gene silencing of MMP-7 which also suppressed the invasiveness of BxPc-3 cells. In conclusion, triterpenes from P. cocos demonstrate anticancer and anti-invasive effects on human pancreatic cancer cells and can be considered as new therapeutic agents in the treatment of pancreatic cancer.
Triterpenes from the fungus Poria cocos and their inhibitory activity on nitric oxide production in mouse macrophages via blockade of activating protein-1 pathway.[Pubmed:22083926]
Chem Biodivers. 2011 Nov;8(11):2135-43.
Two new triterpenes, 29-hydroxydehydrotumulosic acid (1) and 29-hydroxyDehydropachymic acid (2), together with six known compounds, Dehydropachymic acid (3), dehydrotumulosic acid (4), 29-hydroxypolyporenic acid C (5), polyporenic acid C (6), tumulosic acid (7), and pachymic acid (8), were isolated from the dried sclerotia of Poria cocos. In the in vitro bioassays, these isolated compounds reduced, in a dose-dependent manner, nitric oxide (NO) production from lipopolysaccharide (LPS)-induced RAW 264.7 cells, with compounds 5 and 6, the IC(50) values of which were 16.8+/-2.7 and 18.2+/-3.3 muM, respectively, exhibiting the greatest inhibition activity. Further Western blot analysis conducted on cells pre-treated with compounds 5 and 6, and luciferase assays on activator protein 1-dependent gene expression revealed that the inhibited NO release was attributed to the reduced expression of iNOs (=inducible NO synthase) enzymes, which might be regulated via the blockade of activator protein-1 signaling pathway.
